$BNR

Burning Rock Biotech Ltd

  • NASDAQ
  • Health Services
  • Medical/Nursing Services
  • Health Care and Social Assistance
  • Diagnostic Imaging Centers

PRICE

$2.94 โ–ผ-1.01%

Delayed Price

VOLUME

54,899

DAY RANGE

-

52 WEEK

1.74 - 29.16

Join Discuss about BNR with like-minded investors

profile
@achatzi #ivtrades
recently

GM all > @CarlosH said: Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Nov. 23, 2021: $ZM, $EXAS, $CRSP, $NVTA, $MTLS, $VLD, $ACHR, $MKFG, $NIU, $MNDY, $GENI, $ROKU, $HOOD, $NNDM, $CND, $VUZI, $ADPT, $PACB, $SDGR, $BFLY, $BNR, $SURF, $DKNG, $STNE, $TOST, $PLTR

118 Replies 7 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@CarlosH-carvan #ivtrades
recently

Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Nov. 23, 2021: $ZM, $EXAS, $CRSP, $NVTA, $MTLS, $VLD, $ACHR, $MKFG, $NIU, $MNDY, $GENI, $ROKU, $HOOD, $NNDM, $CND, $VUZI, $ADPT, $PACB, $SDGR, $BFLY, $BNR, $SURF, $DKNG, $STNE, $TOST, $PLTR

47 Replies 6 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@Traderbiasa #forexvoxio
recently

betul, itu lokasi sell > @faisholhabas said: mas amy harga saat ini 1.187xx di Hโด tepat berada di area resistance.jd untuk sell limit nomor cantik brada di hrga 1.1890-1.1880-1.1870 apa bnr bgn mas amy @Traderbiasa mohon koreksinya๐Ÿ™๐Ÿ™

148 Replies 13 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@faisholhabas #forexvoxio
recently

mas amy harga saat ini 1.187xx di Hโด tepat berada di area resistance.jd untuk sell limit nomor cantik brada di hrga 1.1890-1.1880-1.1870 apa bnr bgn mas amy @Traderbiasa mohon koreksinya๐Ÿ™๐Ÿ™

53 Replies 7 ๐Ÿ‘ 11 ๐Ÿ”ฅ

Key Metrics

Market Cap

260.95 M

Beta

1.28

Avg. Volume

1.60 M

Shares Outstanding

87.86 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-31

Next Dividend Date

Company Information

Burning Rock Biotech Limited, whose mission is to guard life via science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 273,000 tissue and liquid-based tests completed cumulatively, and ii) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.

Website:

HQ: ,

Related News